3rd Quarter - Report

FERRING PHARMACEUTICALS, INC. for FERRING PHARMACEUTICALS, INC.

Firm
Client
Income
—
Expenses
$260,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to fertility treatment, oncology and coverage, including: H.R. 8119, the HOPE with Fertility Services Act; H.R. 1670 and S. 797, the Family Building FEHB Fairness Act; H.R. 220, the Veterans Infertility Treatment Act; H.R. 7841, Warrior Infertility Act; H.R. 6797, the Bipartisan IVF for Military Families Act; and H.R. 4299, the Protecting Patient Access to Cancer and Complex Therapies Act.

LobbyistCovered position, as disclosed
TIMOTHY CLARK —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4299 (119th), H.R. 6797 (119th), S. 797 (119th), H.R. 1670 (119th), H.R. 7841 (119th), H.R. 220 (119th), H.R. 8119 (119th)

Taxation/Internal Revenue Code TAX

Issues related to establishing a tax credit for fertility treatments, including: H.R. 1878, the IVF Access and Affordability Act; and H.R. 4639, the Infertility Treatment Affordability Act.

LobbyistCovered position, as disclosed
TIMOTHY CLARK —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4639 (119th), H.R. 1878 (119th)

Trade (domestic/foreign) TRD

Issues related to the treatment of pharmaceutical ingredients in trade agreements.

LobbyistCovered position, as disclosed
TIMOTHY CLARK —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.